<?xml version="1.0" encoding="UTF-8"?>
<root>
    <author>ENA</author>
    <category>Sectors</category>
    <date>2025-11-03 17:30:02</date>
    <fulldesc>&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;&lt;strong&gt;New Delhi, Nov 3 (KNN)&lt;/strong&gt; The Department of Biotechnology (DBT) and the Biotechnology Industry Research Assistance Council (BIRAC) will host a high-level Industry Academia Stakeholders Meet on the future of cell and gene therapy (CGT) on November 6, 2025, in New Delhi. &lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;The meeting, titled The New Frontier: Innovation, Regulation and Access in Cell and Gene Therapy, will bring together senior government officials, scientific experts, industry leaders and clinicians to chart a roadmap for advancing Indias CGT ecosystem.&lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;Discussions will focus on developing an enabling regulatory framework, strengthening translational research capabilities, and ensuring safe, equitable and timely access to CGT-based treatments. &lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;Senior representatives from the Central Drugs Standard Control Organisation (CDSCO), the Indian Council of Medical Research (ICMR), the Department of Pharmaceuticals, DBT and BIRAC are expected to participate.&lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;The meeting will also see participation from leading global and domestic stakeholders, including ImmunoACT, Miltenyi Biotec, Novartis, Immuneel Therapeutics, AIIMS, the Centre for Stem Cell Research, and Bric-InStem, among others.&lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;A key agenda item will be advancing work toward a National Policy Mission for Cell and Gene Therapy to strengthen domestic research and manufacturing capabilities and establish streamlined regulatory pathways in this emerging field. &lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;The initiative seeks to position India as a competitive global player in precision medicine, supporting access to advanced therapies for conditions such as genetic disorders, cancers and rare diseases.&lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;Through collaborative deliberations, the event aims to accelerate the growth of Indias biotechnology landscape and bolster national capacity in cell and gene therapy development and delivery.&lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;em&gt;&lt;strong&gt;&lt;span style=&quot;font-size:14px&quot;&gt;(KNN Bureau)&lt;/span&gt;&lt;/strong&gt;&lt;/em&gt;&lt;/p&gt;&#13;
</fulldesc>
    <id>43973</id>
    <link>https://knnindia.co.in/news/newsdetails/sectors/dbt-birac-to-convene-industryacademia-meet-on-cell-gene-therapy-roadmap</link>
    <pubDate>2025-11-03 17:30:02</pubDate>
    <source>knnindia.co.in</source>
    <title>DBT, BIRAC To Convene Industry–Academia Meet On Cell &amp; Gene Therapy Roadmap</title>
</root>
